Media stories about Synopsys (NASDAQ:SNPS) have been trending positive this week, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Synopsys earned a media sentiment score of 0.29 on Accern’s scale. Accern also gave news stories about the semiconductor company an impact score of 46.9875043334256 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the news stories that may have effected Accern Sentiment’s rankings:
- Chi-Foon Chan Sells 3,609 Shares of Synopsys, Inc. (SNPS) Stock (americanbankingnews.com)
- Synopsys, Inc. (SNPS) EVP Joseph W. Logan Sells 10,313 Shares (americanbankingnews.com)
- UBS Asset Management Americas Inc. Sells 5,537 Shares of Synopsys, Inc. (SNPS) (americanbankingnews.com)
- RDL Financial Inc. Invests $1.66 Million in Synopsys, Inc. (SNPS) (americanbankingnews.com)
- Synopsys (SNPS) Lowered to “Strong Sell” at Zacks Investment Research (americanbankingnews.com)
Synopsys (NASDAQ SNPS) traded up $0.23 on Monday, hitting $85.47. The stock had a trading volume of 977,043 shares, compared to its average volume of 1,150,000. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.68 and a quick ratio of 1.04. Synopsys has a twelve month low of $69.42 and a twelve month high of $94.80. The firm has a market capitalization of $12,710.00, a PE ratio of 79.88, a P/E/G ratio of 4.21 and a beta of 1.04.
A number of brokerages have issued reports on SNPS. Zacks Investment Research downgraded Synopsys from a “hold” rating to a “strong sell” rating in a report on Monday. Royal Bank of Canada reaffirmed a “buy” rating on shares of Synopsys in a report on Friday. KeyCorp reiterated an “overweight” rating and set a $110.00 target price (up previously from $106.00) on shares of Synopsys in a research report on Thursday. BidaskClub cut Synopsys from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Finally, JPMorgan Chase & Co. cut Synopsys from a “neutral” rating to an “underweight” rating and set a $87.00 target price on the stock. in a research report on Tuesday, December 12th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $97.33.
In related news, EVP Joseph W. Logan sold 10,313 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $84.69, for a total value of $873,407.97. Following the transaction, the executive vice president now owns 78,584 shares in the company, valued at approximately $6,655,278.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Chi-Foon Chan sold 3,609 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $84.77, for a total value of $305,934.93. Following the completion of the transaction, the chief executive officer now owns 209,244 shares in the company, valued at approximately $17,737,613.88. The disclosure for this sale can be found here. Insiders have sold 79,364 shares of company stock worth $6,959,036 in the last quarter. Insiders own 1.84% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.